These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis. Benbadis S, Klein P, Schiemann J, Diaz A, Elmoufti S, Whitesides J. Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542 [Abstract] [Full Text] [Related]
7. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies. Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K. Neurology; 2016 Jul 19; 87(3):314-23. PubMed ID: 27335114 [Abstract] [Full Text] [Related]
8. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures. Toledo M, Whitesides J, Schiemann J, Johnson ME, Eckhardt K, McDonough B, Borghs S, Kwan P. Epilepsia; 2016 Jul 19; 57(7):1139-51. PubMed ID: 27265725 [Abstract] [Full Text] [Related]
9. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Kwan P, Trinka E, Van Paesschen W, Rektor I, Johnson ME, Lu S. Epilepsia; 2014 Jan 19; 55(1):38-46. PubMed ID: 24116853 [Abstract] [Full Text] [Related]
10. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures. Klein P, Schiemann J, Sperling MR, Whitesides J, Liang W, Stalvey T, Brandt C, Kwan P. Epilepsia; 2015 Dec 19; 56(12):1890-8. PubMed ID: 26471380 [Abstract] [Full Text] [Related]
12. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis. Lee SK, Heo K, Kim SE, Lee SA, Elmoufti S, Laloyaux C, Hur B. Adv Ther; 2021 Jul 19; 38(7):4082-4099. PubMed ID: 34155568 [Abstract] [Full Text] [Related]
13. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program. Brodie MJ, Fakhoury T, McDonough B, Colson AO, Stockis A, Elmoufti S, Whitesides J. Epilepsy Res; 2018 Sep 19; 145():55-62. PubMed ID: 29908435 [Abstract] [Full Text] [Related]
15. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial. Van Paesschen W, Hirsch E, Johnson M, Falter U, von Rosenstiel P. Epilepsia; 2013 Jan 19; 54(1):89-97. PubMed ID: 22813235 [Abstract] [Full Text] [Related]
19. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis. Moseley BD, Dimova S, Elmoufti S, Laloyaux C, Asadi-Pooya AA. Epilepsy Res; 2021 Oct 19; 176():106694. PubMed ID: 34218211 [Abstract] [Full Text] [Related]